ITEMS IN AFP WITH KEYWORD:
What are the effects of antihypertensives and different blood pressure targets in persons with diabetes and hypertension?
Screening high-risk patients for diabetes provides no 10-year mortality benefit.
Diabetic ketoacidosis is characterized by a serum glucose level greater than 250 mg per dL, a pH less than 7.3, a serum bicarbonate level less than 18 mEq per L, an elevated serum ketone level, and dehydration. Insulin deficiency is the main precipitating factor. Diabetic ketoacidosis can occur in p...
The American College of Physicians (ACP) has published an updated guideline on the oral pharmacologic management of type 2 diabetes. Recommendations are based on a systematic evidence review of head-to-head comparisons of oral pharmacologic treatments for type 2 diabetes, and an evidence report spon...
Linagliptin reduces A1C levels to a lesser extent than first-line therapy (metformin) and is significantly more expensive than metformin and sulfonylureas. Importantly, its ability to affect diabetes-related morbidity and mortality is not known.
Dec 15, 2012 Issue
Should the Target A1C Level Be Less Than 7 Percent? Yes: This Should Be the Target for Most Patients [Editorials: Controversies in Family Medicine]
Yes: This Should Be the Target for Most Patients
Dec 15, 2012 Issue
Should the Target A1C Level Be Less Than 7 Percent? No: The Case for Modest Glycemic Control in Patients with Type 2 Diabetes [Editorials: Controversies in Family Medicine]
No: The Case for Modest Glycemic Control in Patients with Type 2 Diabetes
Painful diabetic neuropathy is a chronic disease that affects approximately 16 percent of patients who have diabetes mellitus. The American Academy of Neurology (AAN), the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM), and the American Academy of Physical Medicine and ...
Nearly one-half of persons with chronic kidney disease have diabetes mellitus. Diabetes accounted for 44 percent of new cases of kidney failure in 2008. Diabetic nephropathy, also called diabetic kidney disease, is associated with significant macrovascular risk, and is the leading cause of kidney fa...
May 1, 2012 Issue
Self-Monitoring of Blood Glucose in Patients with Type 2 Diabetes Not Using Insulin [Cochrane for Clinicians]
For patients who have had diabetes longer than one year and are not using insulin, evidence suggests that the benefit of self-monitoring of blood glucose in lowering A1C levels is small at six months and disappears by 12 months. Self-monitoring of blood glucose does not improve health-related qualit...